Smart Tech-Based Nutrition and Exercise for Sarcopenia Risk.
Recruiting
N/A
Interventional Study
Sarcopenia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 65 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- HSIAO MEI LAN · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Sarcopenia, characterized by muscle loss and weakness, is a major health issue among older adults and impacts mobility and quality of life. This study addresses the current lack of long-term, technology-assisted support for managing this condition at home. This randomized controlled trial (RCT) will evaluate a 12-week smart-technology-based program for 60 older adults at risk of sarcopenia.
Inter…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria
Score ≥ 11 on the SARC-CalF questionnaire, indicating risk of sarcopenia.
No evident functional impairment in the limbs and able to complete handgrip strength, walking speed, and muscle mass assessments.
Possesses basic reading, writing, and calculation abilities sufficient to …
Contacts